115. Cancer Lett. 2018 Sep 28;432:17-27. doi: 10.1016/j.canlet.2018.06.003. Epub 2018 Jun 6.Cooperative multi-targeting of signaling networks by angiomiR-204 inhibitsvasculogenic mimicry in breast cancer cells.Salinas-Vera YM(1), Marchat LA(2), García-Vázquez R(2), González de la RosaCH(3), Castañeda-Saucedo E(4), Tito NN(4), Flores CP(5), Pérez-Plasencia C(6),Cruz-Colin JL(7), Carlos-Reyes Á(8), López-González JS(8), Álvarez-Sánchez ME(1),López-Camarillo C(9).Author information: (1)Posgrado en Ciencias Genómicas, Universidad Autónoma de La Ciudad de México,CDMX, Mexico.(2)Programa en Biomedicina Molecular y Red de Biotecnología, InstitutoPolitécnico Nacional, CDMX, Mexico.(3)Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana, CDMX, Mexico.(4)Laboratorio de Biología Celular Del Cáncer. Facultad de CienciasQuímico-Biológicas, Universidad Autónoma de Guerrero, Guerrero, Mexico.(5)Escuela Superior de Medicina, Instituto Politécnico Nacional, CDMX, Mexico.(6)Grupo de Genómica Del Cáncer, Instituto Nacional de Cancerología, CDMX,Mexico.(7)Subdirección de Investigación Básica, Instituto Nacional de Medicina Genómica,CDMX, Mexico.(8)Laboratorio de Cáncer de Pulmón. Instituto Nacional de EnfermedadesRespiratorias "Ismael Cosio Villegas", CDMX, Mexico.(9)Posgrado en Ciencias Genómicas, Universidad Autónoma de La Ciudad de México,CDMX, Mexico. Electronic address: genomicas@yahoo.com.mx.RNA-based multi-target therapies focused in the blocking of signaling pathwaysrepresent an attractive approach in cancer. Here, we uncovered a miR-204cooperative targeting of multiple signaling transducers involved in vasculogenic mimicry (VM). Our data showed that invasive triple negative MDA-MB-231 andHs-578T breast cancer cells, but not poorly invasive MCF-7 cells, efficientlyundergoes matrix-associated VM under hypoxia. Ectopic restoration of miR-204 inMDA-MB-231 cells leads to a potent inhibition of VM and reduction of number ofbranch points and patterned 3D channels. Further analysis of activation state of multiple signaling pathways using Phosphorylation Antibody Arrays revealed thatmiR-204 reduced the expression and phosphorylation levels of 13 proteins involvedin PI3K/AKT, RAF1/MAPK, VEGF, and FAK/SRC signaling. In agreement withphospho-proteomic profiling, VM was impaired following pharmacologicaladministration of PI3K and SRC inhibitors. Mechanistic studies confirmed thatmiR-204 exerts a negative post-transcriptional regulation of PI3K-α and c-SRCproto-oncogenes. Moreover, overall survival analysis of a large cohort of breast cancer patients indicates that low miR-204 and high FAK/SRC levels wereassociated with worst outcomes. In conclusion, our study provides novel lines of evidence indicating that miR-204 may exerts a fine-tuning regulation of thesynergistic transduction of PI3K/AKT/FAK mediators critical in VM formation.Copyright © 2018 Elsevier B.V. All rights reserved.DOI: 10.1016/j.canlet.2018.06.003 PMID: 29885516 